Bioperfectus Obtained CE Mark for the SARS-CoV-2 Antigen Rapid Self-test

Company news
2021-12-28

Bioperfectus is pleased to announce that we have obtained CE Mark for our Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit (Self-test). This test is a lateral flow test intended for non-prescription home use with self-collected nasal swab specimens. It is used to detect symptomatic individuals who are suspected of COVID-19 or asymptomatic individuals who have had contact with confirmed COVID-19 patients but do not show any symptoms.

 

 

Our Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit was previously available as a home test in German and Austrian markets since May 20th, 2021. With the CE Mark, our test has received official approval following the traditional registration pathway and can now also be used in markets that have not established regulatory exemption pathways.

 

 

As the global economy starts to re-open, individuals or communities can follow the easy instruction of our test and detect whether they are infected with SARS-CoV-2 to avoid the further spread of the disease.

 

For further information, please send us an inquiry email: info@bioperfectus.com or  marketing_global@bioperfectus.com.

MOST READ

Bioperfectus Launches a New RT-PCR Kit to Detect COVID-19 New Variant"Omicron"

As a leading manufacturer of molecular diagnostic solutions for infectious diseases, Biopertectus is very proud to announce today that the new SARS-CoV-2 Variant Omicron (B.1.1.529) Real-Time PCR Kit is launched globally. With the detection of the mutation sites of H655Y, N679K, P681H, and E484A, this new kit could help to identify the Omicron variant conveniently and effectively.

2021-12-27

Bioperfectus Whole Blood DNA Extraction Kit is Available Now!

We are proud to inform you that a new member is joining in Bioperfectus extraction solution pipeline.

2021-12-06

Declaration on the Effectiveness of Bioperfectus SARS-CoV-2 Antigen Rapid Test Kit against New Variant Omicron

The spread of the new variant “Omicron” is faster than expected. The countries and regions with reported Omicron cases on the GISAID website have been increased to twenty-one on Dec. 2, 2021. This data only shows the number of submitted sequenced cases, which may be just the tip of the iceberg.

2021-12-02